
- Oncology NEWS International Vol 11 No 3
- Volume 11
- Issue 3
States Fail Minimum Guidelines for Antitobacco Spending
WASHINGTON-Most states get a failing grade in the latest assessment of spending on antitobacco programs. The updated report on how the states are allocating the money they receive from legal settlements with the tobacco industry shows that only five states are providing funds for tobacco prevention programs at or above the lowest amounts recommended by the Centers for Disease Control and Prevention (CDC).
WASHINGTONMost states get a failing grade in the latest assessment of spending on antitobacco programs. The updated report on how the states are allocating the money they receive from legal settlements with the tobacco industry shows that only five states are providing funds for tobacco prevention programs at or above the lowest amounts recommended by the Centers for Disease Control and Prevention (CDC).
CDC guidelines suggest a minimum spending level for each state that ranges from 20% to 25% of the settlement funds a state receives. Only Arizona, Maine, Massachusetts, Mississippi, and Minnesota meet or exceed the suggested minimum, according to the report released by the American Cancer Society, American Heart Association, Campaign for Tobacco-Free Kids, and American Lung Association.
The report also noted that some states have cut the percentage of settlement dollars devoted to tobacco programs because their revenue intakes have diminished as a result of the economic recession. Florida, for example, slashed funds for its highly regarded tobacco control efforts by 20% in December 2001. Tennessee legislators voted to spend all of the state’s settlement funds received thus far to balance its budget for 1 year.
Only 19 states have funded their tobacco programs at or above 50% of the recommended levels; only 16 provide funding at 25% to 50% of the minimum, and 12 support tobacco programs at less than 25% of the minimum. Michigan, North Carolina, Tennessee, and the District of Columbia have committed no major fundingeither from their settlement money or other revenue sources to tobacco prevention.
Articles in this issue
over 23 years ago
Bush to Complete 5-Year Doubling of NIH Budgetover 23 years ago
CAD Accurate in Digital Imagesover 23 years ago
Campath-1H Safe and Effective in Refractory B-CLLover 23 years ago
Involved-Field RT Is Effective in Hodgkin’s Diseaseover 23 years ago
FDA Approves Orfadin for Hereditary Tyrosinemia Type 1over 23 years ago
Allovectin-7 Immunotherapy Active in Metastatic Melanomaover 23 years ago
HAART Ups Survival in Primary CNS Lymphoma Patientsover 23 years ago
DX-8951f/Gemcitabine Safe, Active in Advanced Solid Tumorsover 23 years ago
Pseudomonas aeruginosa Infections After Transplant Rare But Deadlyover 23 years ago
ODAC Recommends That FDA Approve Zometa for Bone MetastasesNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.